Verapamil Hydrochloride
Product Images NDC 59923-606
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Verapamil Hydrochloride (NDC 59923-606). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Areva Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Box-label-4ml (Box Label 4ml)
This is a description of Verapamil HCI Injection USP at a concentration of 2.5 mg/mL. It emphasizes protection from light and intravenous use only. Each mL contains verapamil hydrochloride and sodium chloride. The recommended usage is for slow intravenous injection over a minimum of two minutes. Proper storage conditions at 20° to 25°C are highlighted. The product is presented in 5 x 4 mL single-dose vials. Manufactured by Areva Pharmaceuticals Inc.*
Chemical Structure (Chemical Structure)
Container-label (Container Label)
Logo (Logo)
Vial-label-2ml (Vial Label 2ml)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.